Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations

Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations This pharmacoepidemiology study uses Medicaid data to estimate associations between first-trimester use of intravenous ondansetron and risk of cardiac malformations and oral cleft in children of exposed mothers. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations

Loading next page...
 
/lp/american-medical-association/intravenous-ondansetron-in-pregnancy-and-risk-of-congenital-tLmZShRHYl
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2019.18587
Publisher site
See Article on Publisher Site

Abstract

This pharmacoepidemiology study uses Medicaid data to estimate associations between first-trimester use of intravenous ondansetron and risk of cardiac malformations and oral cleft in children of exposed mothers.

Journal

JAMAAmerican Medical Association

Published: Jan 28, 2020

References